Body composition during treatment with conjugated estrogens with and without medroxyprogesterone acetate: analysis of the women's Health, Osteoporosis, Progestin, Estrogen (HOPE) trial

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 2, 2007, Pages 137.e1-137.e7

  Thorneycroft, Ian H ^a   Lindsay, Robert ^b   Pickar, James H ^c  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b HELEN HAYES HOSPITAL   (United States)

^c PFIZER INC   (United States)

Author keywords

body composition; body weight; conjugated estrogens; Estrogen study; fat body mass; hormone therapy; lean body mass; medroxyprogesterone acetate; Osteoporosis; Progestin; Women's Health

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WOMEN'S HEALTH;

EID: 34547564342     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.05.042     Document Type: Article

References (25)

1. Greendale G.A., Reboussin B.A., Hogan P., et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 92 (1998) 982-988
2. Utian W.H., Shoupe D., Bachmann G., Pinkerton J.V., and Pickar J.H. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 75 (2001) 1065-1079
3. Writing Group for the PEPI Trial. Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 276 (1996) 1389-1396
4. Lindsay R., Gallagher J.C., Kleerekoper M., and Pickar J.H. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA 287 (2002) 2668-2676
5. Bakken K., Eggen A.E., and Lund E. Side effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997. Acta Obstet Gynecol Scand 83 (2004) 850-856
6. Li C., Samsioe G., Lidfelt J., Nerbrand C., and Agardh C.D. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. Menopause 7 (2000) 273-281
7. Di Carlo C., Tommaselli G.A., and Nappi C. Effects of sex steroid hormones and menopause on serum leptin concentrations. Gynecol Endocrinol 16 (2002) 479-491
8. Milewicz A., Tworowska U., and Demissie M. Menopausal obesity-myth or fact?. Climacteric 4 (2001) 273-283
9. Stevenson J.C. Metabolic effects of hormone replacement therapy. J Br Menopause Soc 10 (2004) 157-161
10. Anderson E.J., Lavoie H.B., Strauss C.C., Hubbard J.L., Sharpless J.L., and Hall J.E. Body composition and energy balance: lack of effect of short-term hormone replacement in postmenopausal women. Metabolism 50 (2001) 265-269
11. Espeland M.A., Stefanick M.L., Kritz-Silverstein D., et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. J Clin Endocrinol Metab 82 (1997) 1549-1556
12. Jensen L.B., Vestergaard P., Hermann A.P., et al. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res 18 (2003) 333-342
13. Norman R.J., Flight I.H.K., and Rees M.C.P. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution (Cochrane Review). Cochrane Libr 1 (2002) 1-61
14. Maddalozzo G.F., Cardinal B.J., Li F., and Snow C.M. The association between hormone therapy use and changes in strength and body composition in early postmenopausal women. Menopause 11 (2004) 438-446
15. Di Carlo C., Tommaselli G.A., Sammartino A., Bifulco G., Nasti A., and Nappi C. Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy. Menopause 11 (2004) 466-473
16. Aloia J.F., Vaswani A., Russo L., Sheehan M., and Flaster E. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 172 (1995) 896-900
17. O'Sullivan A.J., Crampton L.J., Freund J., and Ho K.K.Y. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest 102 (1998) 1035-1040
18. dos Reis C.M.R.F., de Melo N.R., Meirelles E.S., Vezozzo D.P., and Halpern A. Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal oestrogen. Maturitas 46 (2003) 59-68
19. Archer D.F., Dorin M., Lewis V., Schneider D.L., and Pickar J.H. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding. Fertil Steril 75 (2001) 1080-1087
20. Pickar J.H., Yeh I.-T., Wheeler J.E., Cunnane M.F., and Speroff L. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 76 (2001) 25-31
21. Pickar J.H., Yeh I.-T., Wheeler J.E., Cunnane M.F., and Speroff L. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two year substudy results. Fertil Steril 80 (2003) 1234-1240
22. Lobo R.A., Bush T., Carr B.R., and Pickar J.H. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism. Fertil Steril 76 (2001) 13-24
23. Reubinoff B.E., Wurtman J., Rojansky N., et al. Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study. Fertil Steril 64 (1995) 963-968
24. Chen Z., Bassford T., Green S.B., et al. Postmenopausal hormone therapy and body composition-a substudy of the estrogen plus progestin trial of the Women's Health Initiative. Am J Clin Nutr 82 (2005) 651-656
25. Hartmann B., Kirchengast S., Albrecht A., Laml T., Bikas D., and Huber J. Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women. Maturitas 22 (1995) 239-246